192 related articles for article (PubMed ID: 11903667)
1. Expression of bcl-2 protein in active skin lesions of Behçet's disease.
Senturk N; Yildiz L; Sullu Y; Kandemir B; Turanli AY
Int J Dermatol; 2001 Dec; 40(12):747-50. PubMed ID: 11903667
[TBL] [Abstract][Full Text] [Related]
2. Fas (CD95) and bcl-2 expression in active skin lesions of Behçet's disease.
Bariş YS; Yildiz L; Sentürk N; Kandemir B
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):569-72. PubMed ID: 16164710
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 expression in skin pathergy reaction of Behçet's disease.
Sullu Y; Senturk N; Yildiz L; Sullu YD; Turanli AY
Dermatology; 2001; 202(2):90-3. PubMed ID: 11306827
[TBL] [Abstract][Full Text] [Related]
4. The significance of immunohistochemistry in the skin pathergy reaction of patients with Behçet's syndrome.
Inaloz HS; Evereklioglu C; Unal B; Kirtak N; Eralp A; Inaloz SS
J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):56-61. PubMed ID: 14678533
[TBL] [Abstract][Full Text] [Related]
5. A histopathological approach: when papulopustular lesions should be in the diagnostic criteria of Behçet's disease?
Kalkan G; Karadag AS; Astarci HM; Akbay G; Ustun H; Eksioglu M
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1056-60. PubMed ID: 19453803
[TBL] [Abstract][Full Text] [Related]
6. Expression of Bcl-2 in inflammatory sites from patients with active Behçet's disease.
Hamzaoui K; Hamzaoui A; Zakraoui L; Chabbou A
Mediators Inflamm; 1999; 8(2):101-6. PubMed ID: 10704147
[TBL] [Abstract][Full Text] [Related]
7. HSP 60 expression in mucocutaneous lesions of Behçet's disease.
Ergun T; Ince U; Ekşioğlu-Demiralp E; Direskeneli H; Gürbüz O; Gürses L; Aker F; Akoğlu T
J Am Acad Dermatol; 2001 Dec; 45(6):904-9. PubMed ID: 11712037
[TBL] [Abstract][Full Text] [Related]
8. The quantification and significance of mast cells in lesions of Behçet's disease.
Lichtig C; Haim S; Hammel I; Friedman-Birnbaum R
Br J Dermatol; 1980 Mar; 102(3):255-9. PubMed ID: 7370173
[TBL] [Abstract][Full Text] [Related]
9. Can specific vessel-based papulopustular lesions of Behçet's disease be differentiated from nonspecific follicular-based lesions clinically?
Boyvat A; Heper AO; Koçyiğit P; Erekul S; Gürgey E
Int J Dermatol; 2006 Jul; 45(7):814-8. PubMed ID: 16863517
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous vasculitis in Behçet's disease: a clinical and histopathologic study of 20 patients.
Chen KR; Kawahara Y; Miyakawa S; Nishikawa T
J Am Acad Dermatol; 1997 May; 36(5 Pt 1):689-96. PubMed ID: 9146529
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Fas ligand expression in lymphocytes in patients with Behçet's disease.
Wakisaka S; Takeba Y; Mihara S; Takeno M; Yamamoto S; Sakane T; Suzuki N
Int Arch Allergy Immunol; 2002 Oct; 129(2):175-80. PubMed ID: 12403936
[TBL] [Abstract][Full Text] [Related]
12. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
13. Caspase-9 expression is increased in endothelial cells of active Behçet's disease patients.
Oztaş P; Lortlar N; Polat M; Alli N; Omeroğlu S; Basman A
Int J Dermatol; 2007 Feb; 46(2):172-6. PubMed ID: 17269970
[TBL] [Abstract][Full Text] [Related]
14. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up.
Özden MG; Caycı YT; Tekin H; Çoban AY; Aydın F; Sentürk N; Bek Y; Cantürk T; Turanlı AY
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630
[TBL] [Abstract][Full Text] [Related]
15. High levels of bcl-2 protein in the T lymphocytes of patients with Behçet's disease.
Hamzaoui A; Hamzaoui K; Kooli C; Chabbou A; Hentati F; Ayed K
Clin Exp Rheumatol; 1996; 14(1):106-7. PubMed ID: 8697647
[No Abstract] [Full Text] [Related]
16. Histopathologic study of cutaneous lesions in Behçet's syndrome.
Chun SI; Su WP; Lee S
J Dermatol; 1990 Jun; 17(6):333-41. PubMed ID: 2384635
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity and specificity of pathergy test results in Israeli patients with Behçet's disease.
Friedman-Birnbaum R; Bergman R; Aizen E
Cutis; 1990 Apr; 45(4):261-4. PubMed ID: 2183974
[TBL] [Abstract][Full Text] [Related]
18. Detection of herpes virus genomes in skin lesions from patients with Behçet's disease and other related inflammatory diseases.
Tojo M; Zheng X; Yanagihori H; Oyama N; Takahashi K; Nakamura K; Kaneko F
Acta Derm Venereol; 2003; 83(2):124-7. PubMed ID: 12735641
[TBL] [Abstract][Full Text] [Related]
19. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.
Todaro M; Zerilli M; Triolo G; Iovino F; Patti M; Accardo-Palumbo A; di Gaudio F; Turco MC; Petrella A; de Maria R; Stassi G
Arthritis Rheum; 2005 Jul; 52(7):2179-91. PubMed ID: 15986355
[TBL] [Abstract][Full Text] [Related]
20. Erythema nodosum-like lesions in Behçet's disease: a clinicopathological study of 26 cases.
Misago N; Tada Y; Koarada S; Narisawa Y
Acta Derm Venereol; 2012 Nov; 92(6):681-6. PubMed ID: 22504656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
